Author: staff

Stocks to Trade

Why Galera Therapeutics (GRTX) Stock Is Surging Today?

Galera Therapeutics, Inc. (NASDAQ: GRTX) is experiencing a notable surge in its stock price today, with a 4.32% increase, reaching $3.14 during early trading. In the previous session, Galera Therapeutics’ shares concluded at $3.01. The rise in GRTX stock is attributed to receiving regulatory approval.

Equities Feed

Why Did SCWorx (WORX) Stock Rise In Extended Trades?

SCWorx Corp. (Nasdaq: WORX) has seen its stock price rise by 5.00% to $0.4622 in Tuesday’s after-hours trading session. The increase in stock price was due to the company’s recent success in winning a new healthcare customer. This is a positive development for the company

NNOX Stock
Market Summary

Why Did Fusion Fuel (HTOO) Stock Gain Traction After-Hours?

On Friday, Fusion Fuel Green PLC (NASD: HTOO) had been moving up in the after-hours trading market with its share prices seeing a noticeable increase of 3.05%. At last check, the shares were trading at $4.05, which is a result of the company entering into

Trending News

What Motivated Vyant Bio (VYNT) Stock To Climb 116%?

After learning that the biotechnology business is looking at strategic options, shares of Vyant Bio Inc. (Nasdaq: VYNT) were up 116.94% at $1.67 at the time of our last check in pre-market trading. What action did VYNT take? LifeSci Capital has been hired by Vyant

Market Summary

How Did The SCYNEXIS (SCYX) Stock Surge In The Extended Session, Jumping 12%?

After receiving a research grant, SCYNEXIS Inc. (NASD: SCYX) has increased 12.50% to $1.80 in after-hours trading on the latest check Thursday. How much funding has SCYX received? Researchers at Case Western Reserve University in Cleveland have received a competitive research grant from the National

Equities Feed

SenesTech (SNES) Stock Rose 8% After-Hours. How Did That Happen?

Shares of SenesTech Inc. (Nasdaq: SNES) were trading 8.33% higher at $2.86 as of the most recent check in after-hours trading. Following the news of a substantial deployment by the specialists in rodent fertility control and creators of ContraPest, the only rat contraceptive approved by

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.